Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.01
-2.05 (-1.50%)
Streaming Delayed Price
Updated: 12:43 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
54
55
Next >
Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning
September 27, 2023
In a significant development, the FDA has updated the labeling for Novo Nordisk A/S's (NYSE: NVO) Ozempic, a diabetes drug known for its weight loss side effect, to include warnings about reports of...
Via
Benzinga
Exposures
Product Safety
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
September 27, 2023
The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's (NYSE
Via
Benzinga
NYSE:NVO stands out as a growth opportunity that won't break the bank.
September 26, 2023
NYSE:NVO, a growth stock which is not overvalued.
Via
Chartmill
Don't overlook NYSE:NVO—a stock with solid growth prospects and a reasonable valuation.
September 22, 2023
In the world of growth stocks, NYSE:NVO shines as a value proposition.
Via
Chartmill
Novo Nordisk Unusual Options Activity For September 21
September 21, 2023
Via
Benzinga
2 Magnificent Dividend Stocks to Buy Right Now
September 26, 2023
These two expensive dividend stocks are worth the price of admission.
Via
The Motley Fool
Which High-Profile Stock-Split Stock Is the Cheapest? Get Ready to Be Shocked...
September 25, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one clear-cut stock-split stock that's notably cheaper than the rest.
Via
The Motley Fool
WW International Shares Jump On BCBS Michigan's Revised Authorization For Wegovy, Other Weight Loss Drugs
September 22, 2023
Via
Benzinga
Stock Market Falls Into Correction On Hawkish Fed: Weekly Review
September 22, 2023
Treasury yields surged to long-term highs, while leading stocks buckled.
Via
Investor's Business Daily
Where Will Novo Nordisk Stock Be in 5 Years?
September 22, 2023
Weight-loss treatments are a big part of Novo Nordisk's business and could be key to its growth for years to come.
Via
The Motley Fool
Why Novo Nordisk Stock Dipped Today
September 18, 2023
Popularity has its downsides.
Via
The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,700 Today
September 14, 2023
Via
Benzinga
Why Novo Nordisk Stock Was Tumbling on Thursday
September 21, 2023
A downbeat analyst take resonated with investors.
Via
The Motley Fool
Coca-Cola Short Seller Says Dominance Fizzles In Face Of Bubbly Upstarts, Weight Loss Drugs
September 21, 2023
Coca-Cola short seller says market dominance is fading to competitors and weight-loss drugs such as Ozempic.
Via
Benzinga
FDA Inspection Turns Up 'Objectionable' Bacteria In Key Novo Nordisk Plant
September 21, 2023
The company says it has since corrected the issues found in the FDA inspection.
Via
Investor's Business Daily
Exposures
Product Safety
Why Novo Nordisk Stock Edged Higher Today
September 20, 2023
The good news outweighed the bad for the hot drug developer on Hump Day.
Via
The Motley Fool
Ypsomed To Supply Autoinjectors To Novo Nordisk Under Long-Term Agreement
September 20, 2023
Swiss medical technology company Ypsomed (OTC: YPHDF) announced a long-term supply
Via
Benzinga
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
September 20, 2023
Eli Lilly And Co (NYSE: LLY) has taken
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Bloomberg
Via
Benzinga
Novo Nordisk Partners With South Africa-Based Aspen To Supply Insulin For African Countries
September 19, 2023
Novo Nordisk A/S (NYSE: NVO) announced a new partnership with&
Via
Benzinga
Single Bitcoin In 2021 Was Enough To Purchase A Tesla Model Y, Softbank Explores Investing In OpenAI, Ford Faces UAW Strike In US, Canada: Today's Top Stories
September 18, 2023
Benzinga
Via
Benzinga
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
September 18, 2023
The FDA reportedly inspected a Novo facility charged with making diabetes and weight-loss drugs.
Via
Investor's Business Daily
Exposures
Product Safety
Quality Control Issues at Novo Nordisk's Clayton Plant - Key Site for Weight-Loss, Diabetes Drug Production
September 18, 2023
The FDA has reportedly issued a report detailing quality control lapses at Novo Nordisk A/S's (NYSE: NVO) Clayton, North Carolina plant.
Via
Benzinga
Exposures
Product Safety
3 Phenomenal Stock-Split Stocks You Should Be Buying Now
September 18, 2023
These three fantastic stock-split stocks are stocks investors should be buying in the wake of last year's wave of splits.
Via
InvestorPlace
3 Stock-Split Stocks Billionaire Investors Can't Stop Buying
September 18, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three highfliers Wall Street's top managers are piling into.
Via
The Motley Fool
Yet Again, Ozempic Could Soon Get Even Better for Novo Nordisk Stock
September 16, 2023
The results of a small new study could open the door to yet another market.
Via
The Motley Fool
The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023
September 15, 2023
Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential
Via
InvestorPlace
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
September 15, 2023
The rhetoric surrounding popular businesses isn't always good advice.
Via
The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2023
Revenue at all three companies improved last quarter, and their share prices have followed suit.
Via
The Motley Fool
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.